Animal models that recapitulate various disease mechanisms seen in AD and related tauopathies are no less valuable for preclinical studies for drug development than transgenic mouse and rat models in which one or more mutated human proteins are overexpressed to produce Aβ plaques and/or tau neurofibrillary tangles. The gene discussed is MAPT; the disease is tauopathy.